Newsbot

Should Value Investors Buy Yum China (YUMC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy CBIZ (CBZ) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Central Japan Railway Co. (CJPRY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing ARMOUR Residential REIT (ARR) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Gentherm (THRM) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing UMB Financial (UMBF) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Virtu Financial (VIRT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Stock Market News for Sep 22, 2026

U.S. stocks closed sharply higher on Monday, led by a tech rally, while investors breathed a sigh of relief as Treasury yields slid from their recent highs and oil prices dropped to an 11-day low.

Lyft Aktie: Freenow-Vergleich könnte Anleger enttäuschen

New York (www.aktiencheck.de) - Lyft-Aktienanalyse von BTIG:Die Analysten von BTIG bestätigen ihr Rating "neutral" für die Aktie von Lyft Inc. (ISIN: US55087P1049, WKN: A2PE38, Ticker-Symbol: LY0, NASDAQ-Symbol: LYFT).Die Konsensschätzungen für das Wachstum der Fahrtenzahl im zweiten Halbjahr 2026 seien mit Risiken behaftet. [mehr]

RBC belässt Zurich auf Outperform - Ziel 650 Franken

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Zurich auf "Outperform" mit einem Kursziel von 650 Franken belassen. Bei der jüngsten Veranstaltung des Versicherers hätten die Übernahme von Beazley, die Entwicklung in den verschiedenen Schaden- und Unfallversicherungssparten sowie Kapitalausschüttungen als Teil des nächsten Strategieplans im Fokus gestanden, schrieb Ben Cohen in einer am Dienstag vorliegenden Einschätzung. [mehr]

CoreWeave Aktie: BTG Pactual startet mit Kaufempfehlung - warum das Kursziel 125 USD elektrisiert

Bad Marienberg (www.aktiencheck.de) - Kurzer Datenabgleich: Die **Ersteinschätzung von BTG Pactual vom 21. September 2026 mit "Buy" Die Aktie von CoreWeave Inc. (ISIN: US21873S1087, WKN: A413X6, Ticker-Symbol: I1V, NASDAQ-Symbol: CRWV) meldet sich mit Macht zurück: Nach einem Kurssprung von 5,0 % auf 85,43 USD am Montag bekommt die KI-Infrastrukturstory nun zusätzlichen Rückenwind von der Wall Street. [mehr]

Wall Street Bulls Look Optimistic About B2Gold (BTG): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in B2Gold (BTG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?